Curcumin-Docetaxel Nanoparticles Blocked 77% of Lung Metastases in Triple-Negative Breast Cancer — Mouse Study
In cell and mouse models of triple-negative breast cancer, carrier-free curcumin-docetaxel nanoparticles suppressed tumor growth by 74.5% and postoperative lung metastasis by 77.1%, via NF-kB/EMT modulation. Preclinical — not tested in patients.
By Sanare Lab · October 14, 2026 · 2 min read
Key Takeaway
Particles built only from curcumin (turmeric's active compound), a chemo drug and a dye slowed breast cancer in mice and cut lung spread by 77% — no patient has received it yet.
Chemotherapy for advanced breast cancer can fuel inflammation that helps it spread. The team built "carrier-free" nanoparticles — particles assembled only from drug molecules, no filler — combining docetaxel (a standard breast-cancer chemo), curcumin (turmeric's anti-inflammatory compound), and indocyanine green (a tracking dye).
In cultures, the particles slowed triple-negative breast cancer cells (an aggressive type lacking the three common drug targets) and their migration. In mice they shrank tumors by 74.5% and cut postoperative lung metastasis — cancer colonies in the lungs after surgery — by 77.1%. Blood levels of TNF-α, IL-6 and IL-1β (inflammatory signaling proteins) fell; the particles dampened NF-κB (a switch that turns on inflammation genes) and partially reversed EMT — the process where tumor cells loosen and become mobile.
This was cells and mice only: mouse results often fail in people, and curcumin alone is poorly absorbed (see why curcumin is so hard to deliver). Related: an earlier curcumin-and-NF-κB breast cancer study. Dosing: our dosing calculator.
In plain words
What happened: Scientists made tiny particles from two medicines — curcumin from turmeric and the chemo drug docetaxel — and tested them on aggressive breast cancer in lab dishes and mice.
Why it matters: Chemo can stir inflammation that helps breast cancer spread. Curcumin calms inflammation, so the pair might hit tumor and spread at once.
How strong is the evidence: Early work: cells and mice only. Tumors shrank ~75% and lung spread fell 77%, but mouse results often fail to translate — no patient has received it.
What it means for you: Nothing changes today; capsules cannot copy these injected particles — do not try at home. Ask your oncologist about trials.
Shop Sanare Lab
Lab-tested products referenced in the research above — order direct from Sanare Lab.
Daily adjunct
Curcumin 360 mg
95% curcuminoids with black pepper extract.
Prices checked September 2026 and may change; the store page shows the current price.
Disclaimer: Links are informational and for convenience. This site does not provide medical advice. Always verify product quality, labeling, and consult a licensed professional for health decisions.
References
- Carrier-Free Cur/DTX@ICG Ternary Nanoparticles for Suppressing Lung Metastasis in Triple-Negative Breast Cancer (preclinical — cells and mice, not yet tested in patients). Small. 2026 Oct 13. doi:10.1002/smll.76217. PMID: 42865332.
Medical Disclaimer
This article is informational, not medical advice. Research in cells and animals cannot predict effects in people. Never change medication without consulting your doctor.
Sanare Lab
Science-based health education team reviewing published research on repurposed drugs, integrative oncology, and evidence-based protocols.